231 related articles for article (PubMed ID: 24931571)
21. Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7.
Shi Q; Gao Y; Xu S; Du C; Li F; Tang XS; Jia J; Wang X; Chang L; He D; Guo P
Urol Oncol; 2016 Feb; 34(2):58.e11-8. PubMed ID: 26480897
[TBL] [Abstract][Full Text] [Related]
22. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
[TBL] [Abstract][Full Text] [Related]
23. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.
Dong JT; Chen C
Cell Mol Life Sci; 2009 Aug; 66(16):2691-706. PubMed ID: 19448973
[TBL] [Abstract][Full Text] [Related]
24. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
25. Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration.
Zhang B; Ci X; Tao R; Ni JJ; Xuan X; King JL; Xia S; Li Y; Frierson HF; Lee DK; Xu J; Osunkoya AO; Dong JT
Nat Commun; 2020 Feb; 11(1):997. PubMed ID: 32081850
[TBL] [Abstract][Full Text] [Related]
26. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
Nakajima Y; Akaogi K; Suzuki T; Osakabe A; Yamaguchi C; Sunahara N; Ishida J; Kako K; Ogawa S; Fujimura T; Homma Y; Fukamizu A; Murayama A; Kimura K; Inoue S; Yanagisawa J
Sci Signal; 2011 Apr; 4(168):ra22. PubMed ID: 21487105
[TBL] [Abstract][Full Text] [Related]
27. CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
Wu Q; Fu C; Li M; Li J; Li Z; Qi L; Ci X; Ma G; Gao A; Fu X; A J; An N; Liu M; Li Y; King JL; Fu L; Zhang B; Dong JT
Int J Cancer; 2019 Feb; 144(3):582-594. PubMed ID: 30289973
[TBL] [Abstract][Full Text] [Related]
28. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line.
Chen C; Benjamin MS; Sun X; Otto KB; Guo P; Dong XY; Bao Y; Zhou Z; Cheng X; Simons JW; Dong JT
Int J Cancer; 2006 Mar; 118(6):1346-55. PubMed ID: 16184550
[TBL] [Abstract][Full Text] [Related]
29. KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1.
Ma JB; Bai JY; Zhang HB; Jia J; Shi Q; Yang C; Wang X; He D; Guo P
Cell Death Dis; 2020 Jun; 11(6):466. PubMed ID: 32546700
[TBL] [Abstract][Full Text] [Related]
30. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
[TBL] [Abstract][Full Text] [Related]
31. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
32. The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation.
Diakiw SM; D'Andrea RJ; Brown AL
IUBMB Life; 2013 Dec; 65(12):999-1011. PubMed ID: 24323942
[TBL] [Abstract][Full Text] [Related]
33. TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer.
Ellenrieder V
Anticancer Res; 2008; 28(3A):1531-9. PubMed ID: 18630508
[TBL] [Abstract][Full Text] [Related]
34. Suppression of KLF5 basal expression in oral carcinoma-derived cells through three intact CREB1-binding sites in the silencer region.
Katsuumi R; Negishi T; Imai K; Mihara N
J Oral Biosci; 2024 Mar; 66(1):217-224. PubMed ID: 38147910
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
36. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.
Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW
Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325
[TBL] [Abstract][Full Text] [Related]
37. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
Chen C; Bhalala HV; Vessella RL; Dong JT
Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation.
Li D; Yea S; Dolios G; Martignetti JA; Narla G; Wang R; Walsh MJ; Friedman SL
Cancer Res; 2005 Oct; 65(20):9216-25. PubMed ID: 16230382
[TBL] [Abstract][Full Text] [Related]
39. Suppression of Krüppel-like factor 5 basal expression by CREB1 binding to far distal element.
Mihara N; Imai K
Tumour Biol; 2023; 45(1):81-94. PubMed ID: 37694332
[TBL] [Abstract][Full Text] [Related]
40. Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5.
Lee SJ; No YR; Dang DT; Dang LH; Yang VW; Shim H; Yun CC
J Biol Chem; 2013 Aug; 288(35):25244-25253. PubMed ID: 23880760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
